257 related articles for article (PubMed ID: 23134447)
1. New developments in endocervical glandular lesions.
McCluggage WG
Histopathology; 2013 Jan; 62(1):138-60. PubMed ID: 23134447
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions.
Liang L; Zheng W; Liu J; Liang SX
Arch Pathol Lab Med; 2016 Feb; 140(2):148-52. PubMed ID: 26910219
[TBL] [Abstract][Full Text] [Related]
3. Endocervical glandular lesions: controversial aspects and ancillary techniques.
McCluggage WG
J Clin Pathol; 2003 Mar; 56(3):164-73. PubMed ID: 12610091
[TBL] [Abstract][Full Text] [Related]
4. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas.
McCluggage WG; Sumathi VP; McBride HA; Patterson A
Int J Gynecol Pathol; 2002 Jan; 21(1):11-5. PubMed ID: 11781517
[TBL] [Abstract][Full Text] [Related]
5. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
6. The developing spectrum of gastric-type cervical glandular lesions.
Talia KL; McCluggage WG
Pathology; 2018 Feb; 50(2):122-133. PubMed ID: 29233547
[TBL] [Abstract][Full Text] [Related]
7. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
Mikami Y; McCluggage WG
Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
[TBL] [Abstract][Full Text] [Related]
8. The expression of epithelial specific antigen in cervical intraepithelial neoplasia and adenocarcinoma.
Markaki S; Lazaris D; Papaspirou I; Paulou V
Eur J Gynaecol Oncol; 2004; 25(1):101-3. PubMed ID: 15053074
[TBL] [Abstract][Full Text] [Related]
9. Premalignant lesions of the lower female genital tract: cervix, vagina and vulva.
McCluggage WG
Pathology; 2013 Apr; 45(3):214-28. PubMed ID: 23442737
[TBL] [Abstract][Full Text] [Related]
10. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
11. The spectrum of cervical glandular neoplasia and issues in differential diagnosis.
Loureiro J; Oliva E
Arch Pathol Lab Med; 2014 Apr; 138(4):453-83. PubMed ID: 24678677
[TBL] [Abstract][Full Text] [Related]
12. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
[TBL] [Abstract][Full Text] [Related]
13. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
14. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
15. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR
Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
Jones MW; Onisko A; Dabbs DJ; Elishaev E; Chiosea S; Bhargava R
Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
[TBL] [Abstract][Full Text] [Related]
17. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
[TBL] [Abstract][Full Text] [Related]
18. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
Liou S; Nilforoushan N; Kang Y; Moatamed NA
Diagn Pathol; 2021 Sep; 16(1):85. PubMed ID: 34544445
[TBL] [Abstract][Full Text] [Related]
19. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?
Liao CL; Hsu JD; Lee MY; Kok LF; Li YJ; Wang PH; Yao CC; Han CP
Virchows Arch; 2010 Apr; 456(4):377-86. PubMed ID: 20221633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
